NiMin Energy taps out two years post-IPO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Power-One predicts European solar revival in Q2
Signs of a resurgence in its European market prompted Power-One to project better-than-expected second-quarter profits on May 3 even as it said that first-quarter income dropped 84.1 percent to $4.9 million, or 3 cents per diluted share. Net sales were up 8.3 percent to $225.8 million. The company’s renewable energy division contributed $149 million to Read More →
ValueClick shares drop 22% on Q2 outlook
Shares of online advertising firm ValueClick plunged 22.2 percent after the Westlake Village-based firm projected lower-than-expected second-quarter revenues of between $155 million and $160 million. One analyst told Bloomberg News that the company is reducing traffic in its owned-and-operated website segment. ValueClick reported first-quarter profits of $21.6 million – 27.8 percent above the same quarter Read More →
Ventura startup aims to make real estate sales a social business
Ventura Home Team wants to put a socially responsible spin on real estate selling.
ATA growth leads manufacturing rebirth in Paso
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Ringing in retirement: Santa Barbara firms team up on baby boomer effort
You know what age you’d like to retire at, but you’ve probably averted your eyes from the horrors of your 401(k) in recent years. But when will you actually be able to retire? And what if the answer contains three digits? Those are the questions that FreeRetirementReport.com, the brainchild of veteran Santa Barbara asset manager Read More →
Amgen to buy Turkish firm in $700M deal
Thousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
